Score Breakdown
Offering Ability
72
Cash Runway
65
Float Risk
22
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 44%
🔄 Reverse Split
model est. 65%
• 50-day avg $0.83 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise
model 33%
• Under 12 months cash (10mo)
• Active ATM program with $20M remaining capacity
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (64/100)
Market Data
Market Cap$288.62M
Shares Outstanding277.80M
Float190.79M
Cash$79.90M
Debt$36.32M
Short InterestN/A
Institutional Holdings
26.6% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest31.49M
Days to Cover6.9
% of Float16.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2023-12-31
424B3
ATM
2026-03-19
8-K
8K EVENT
2026-03-19
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual HUMA Dilution Snapshot
Humacyte, Inc. (HUMA) has a DilutionScore of 64/100, rated High dilution risk. Score date: August 28, 2026.
- Stored ATM program remaining capacity: $20.0M.
- Recent SEC activity tracked for HUMA: 424B3 on 2026-03-19; 8-K on 2026-03-19; xbrl on 2023-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: